Similarly, TET3 increases the 5hmC levels in the binding site to the E2F1 transcription factor in the Epithelial Splicing Regulatory Protein 1 (ESRP1) promoter, inducing its expression under hypoxic conditions in MCF-7 BC cells [86]. Here, TET3 is linked to breast cancer.